General practitioner contacts, hospitalizations, and nursing home transfers in older patients up to three years after new cancer diagnosis: Results from a large data linkage cohort study.

Authors

null

Victoria Depoorter

KU Leuven, Leuven, Belgium

Victoria Depoorter , Katrijn Vanschoenbeek , Lore Decoster , Harlinde De Schutter , Philip R. Debruyne , Inge DeGroof , Dominique Bron , Frank Cornélis , Sylvie Luce , C. N. J. Focan , Vincent Verschaeve , Gwenaelle Debugne , Christine M. L. H. Langenaeken , Heidi Van Den Bulck , Jean-Charles Goeminne , Koen Milisen , Johan Flamaing , Cindy Kenis , Freija Verdoodt , Hans Wildiers

Organizations

KU Leuven, Leuven, Belgium, Belgian Cancer Registry (BCR), Brussels, Belgium, University Hospital, Brussels, Belgium, General Hospital Groeninge, Kortrijk, Belgium, GZA - Sint-Augustinus, Wilrijk, Belgium, Institut Jules Bordet, Brussels, Belgium, Cliniques Universitaires Saint-Luc - UCLouvain, Brussels, Belgium, University Hospital Erasme, Brussels, Belgium, Clinique Saint-Joseph - CHC-Liège Hospital Group, Liège, Belgium, Grand Hôpital de Charleroi, Charleroi, Belgium, Centre Hospitalier de Mouscron, Mouscron, Belgium, AZ Klina, Brasschaat, Belgium, Imelda Hospital, Bonheiden, Belgium, CHU-UCL-Namur site Sainte Elisabeth, Namur, Belgium, University Hospitals Leuven, Leuven, Belgium

Research Funding

Other Foundation

Background: Long-term outcomes after cancer diagnosis in older persons are largely unexplored because of limited follow-up in clinical studies. By linking clinical data with population-based data, studying long-term outcomes in large cohorts becomes feasible. The current study aims to explore long-term outcomes in the care trajectory of older patients with cancer and to assess their association with baseline geriatric screening and assessment (GS/GA) results. Methods: A large cohort study of older patients with a new cancer diagnosis was set up by linking clinical, cancer registry and administrative health data based on a unique patient identifier. Clinical data were derived from a previously performed prospective multicentric Belgian study (2009-2015). Patients aged ≥ 70 years were screened with G8 followed by GA in case of an abnormal result (≤14/17). Tumor characteristics and vital status were derived from cancer registry data and long-term outcomes (general practitioner (GP) contacts, hospitalizations and nursing home transfers) from administrative health data. In patients that survived at least 3 months since inclusion, outcomes were assessed from the day after inclusion until 3 years after. Event rates were calculated using person-time at risk to allow for varying follow-up time. Patients were censored 3 months before death to exclude influence of end-of-life care. Results: After data linkage, 6,391 older patients with a new cancer diagnosis were available for this analysis. The median age was 77 (range: 70–100) and 59.8% was female. Diagnoses included solid (92.8%) and hematologic malignancies (7.2%). In the patients with a solid tumor, breast, colorectal and lung cancer were the most common and 20.1% of patients had stage IV. 64.3% of patients had an abnormal baseline G8 score. During the 3 year follow-up, 2,602 (40.7%) of the included patients died. In these 3 years, 5,985 (95.2%) patients had at least one contact with a GP and 4,634 (72.5%) had at least one new hospital admission (event rates in Table 1). Of the 3,724 patients living independently at inclusion and still alive after 3 years, 281 (7.5%) had been transferred to a nursing home and of those, 240 (85.4%) patients had an abnormal baseline G8 score. Conclusions: Older patients with an abnormal baseline G8 score have more GP contacts, hospital admissions and nursing home transfers in the 3 years following a new cancer diagnosis compared to patients with normal baseline G8 score. Baseline G8 could help identify patients at risk for higher long-term healthcare utilization.

Event rate per person-year for GP contacts and hospitalizations.

All pts

(n = 6,391)
Pts with normal G8 score (> 14/17)
(n = 2,281)
Pts with abnormal G8 score (≤ 14/17)
(n = 4,110)
GP contacts (n = 101 missing)
10.968.9512.47
Hospital admissions0.910.721.06

GP = general practitioner, pts = patients.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Symptoms and Survivorship

Track

Symptom Science and Palliative Care

Sub Track

Geriatric Models of Care

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 12041)

DOI

10.1200/JCO.2022.40.16_suppl.12041

Abstract #

12041

Poster Bd #

287

Abstract Disclosures

Similar Abstracts

Abstract

2021 ASCO Quality Care Symposium

Hospitalization burden and end-of-life (EOL) care in elderly patients with glioblastoma (GBM).

First Author: Laura Donovan

First Author: Maria Regina Girones Sarrio